Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06747988

Feasibility and Prospective Study of a Dynamic Traction Device for Use During ESD

The goal of this prospective study at Baylor St. Luke's Medical Center is to investigate the the efficacy and safety of using the novel TTS helix tack suture device as a dynamic traction device during colon and gastric endoscopic submucosal dissection (ESD). The investigators of this study hypothesize that a dynamic traction during ESD can be less traumatic than with other traction devices.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Endoscopic submucosal dissection (ESD) is the mainstay of treatment for complex gastrointestinal polyps, particularly those with a higher risk of superficial submucosal invasion. To facilitate endoscopic dissection, traction is frequently used, particularly in tough locations or when fibrosis is present [1]. Traction assisted ESD is particularly attractive when other techniques, such as tunneling or pocket formation, are not effective.

Tissue traction can be applied by several methods including gravity, mucosal tension, water pressure, and adjusting the patient's body position [2]. Additionally, traction can also be applied using devices such as clip and line, snare, band assisted or using dedicated over-the-scope devices, which can be cumbersome and costly. Despite multiple publications about the efficacy of traction devices in the East, there are few published data from the West [3]. Furthermore, an easy to use through the scope (TTS) dynamic traction device has yet to be developed. Recently, a novel TTS helix tack and suture device (X-tack, Apollo Endosurgery, Austin, Tex, USA) was FDA approved to help facilitate closure of post-resection defects [4]. However, clinical experience suggests the tack and suture system can also be used as a form of dynamic traction during ESD, similar to effective techniques using traditional suture-pulley systems for countertraction during ESD [5]. The traditional suture-pulley system, however, can be cumbersome to assemble as multiple parts are needed to configure it appropriately [6]. Additionally, attaching the suture to the designated areas requires use of multiple costly clips and if repositioning is needed, removal of the clip can be traumatic to the tissue. With the novel TTS suture system (X-tack), four tacks are already assembled along one suture line, thus a suture-pulley countertraction system can be employed without having to assemble multiple parts. In addition, the degree and angulation of traction can be altered simply by pulling, releasing or even redirecting the suture towards a different axis, supporting a dynamic traction during ESD. Finally, removal of the tack, if required, can be less traumatic than with other traction devices. Despite its potential advantages, use of X-tack as countertraction pulley system during ESD has not been formally studied. We looked to investigate the efficacy and safety of using the novel TTS helix tack suture device as a dynamic traction device during colon and gastric ESD.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient is ≥ 18 years old.
  • Patients can provide informed consent.
  • The patient is referred for ESD procedure of colonic or gastric neoplastic lesions and with one of the following criteria:

A- Lesions with prior failed resection of any size. B- Granular lateral spreading tumors (GLST) more than 30 mm. C- Non granular lateral spreading tumors (NGLST) more than 20 mm. D- Any lesion with suspected superficial submucosal invasion. E- Subepithelial lesions.

Exclusion criteria

  • The patient is < 18 years old.
  • The patient refuses and/or is unable to provide consent.
  • The patient is a pregnant woman.
  • Lesions with morphology: pedunculated type (Paris Ip, Ips).
  • Appendiceal orifice or IC valve lesions
  • Patients with lesions removed with other techniques besides ESD (submucosal tunneling technique [STER] or EMR).

Treatment and study plan

Traction Device

Device

After circumferential incision and trimming the submucosa at the incision's edge, dissection is initiated until approximately 20 to 30% of the anal side (for colonic lesions) or oral side (for gastric lesions) of lesion has been dissected leaving a flap of at least 1 cm in length. Once the mucosal flap is created the X-tack device is introduced through the endoscope channel. The first tack is placed on the opposite wall of the lesion, the 2nd and 3rd tack will then be placed next to each other on the mucosal flap portion of the lesion. The 4th tack does not have to be placed but can be used to generate further traction at any time. Clips can be placed along the suture and clipped to the wall at any point to change angulation of traction. The sutures can then be cut and released from the tissue

Primary outcomes

  1. Technical success

    Time frame: Day 1 (procedure day)

    Being able to dissect the lesion to facilitate en bloc removal (removal of the entire tumor endoscopically in one piece)

Secondary outcomes

  1. Dissection speed

    Time frame: Day 1 (procedure day)

    Length of time to perform endoscopic submucosal dissection by the operator as measured by calculating area of lesion divided by time (cm^2/hours).

  2. R0 and curative resection rates

    Time frame: Day 1 (procedure day)

    As collected

  3. Total procedure time

    Time frame: Day 1 (procedure day)

    Total procedure time to perform ESD from scope in to scope out

  4. NASA Task Load Index

    Time frame: Day 1 (procedure day)

    Method assesses work load on five 7-point scales. Increments of high, medium and low

  5. Intraprocedural adverse events

    Time frame: Day 1 (procedure day), up to 48 hours after procedure.

    Such as musclaris propria injury and bleeding (related to or not related to the traction devices).

  6. Post-procedural adverse events

    Time frame: 1 month post-procedure

    As reported per subject follow-ups with the patient within 1 month.

  7. Abdominal pain

    Time frame: 1 hour post-procedure, 24 hours post-procedure.

    Collected at 1 hour and 24 hours after procedure utilizing the Visual analogue scale (VAS)

Sponsors and collaborators

Lead sponsor

Baylor College of Medicine

Other

Registry information

Official study title

Prospective Study Evaluating the Use of a Novel Through - the- Scope Suturing System as a Dynamic Traction Device During ESD: A Feasibility Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 24, 2024
Registry last updated
Dec 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.